Economic effects of clinical pharmacy interventions: A literature review

被引:94
作者
De Rijdt, Thomas [1 ]
Willems, Ludo
Simoens, Steven [2 ]
机构
[1] Univ Hosp Leuven, Dept Pharm, B-3000 Louvain, Belgium
[2] Univ Louvain, Res Ctr Pharmaceut Care & Pharmacoecon, Louvain, Belgium
关键词
clinical pharmacists; clinical pharmacy; interventions; methodology; pharmaceutical services; pharmacoeconomics; research;
D O I
10.2146/ajhp070506
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. Economic evaluations of clinical pharmacy interventions are reviewed. Summary. A variety of clinical pharmacy interventions have been assessed, but the body of evidence relating to any particular type of intervention is small. Cost-saving interventions comprise a small percentage of clinical pharmacy interventions, but they generated substantial savings. Clinical pharmacists provided added value by participating in multidisciplinary teams attending rounds. Clinical pharmacy interventions reduced preventable adverse drug events and prescribing errors, thereby yielding savings related to cost avoidance. Interventions relating to antibiotic therapy lowered costs of care without adversely affecting clinical outcomes. The results of cost-benefit analyses suggested that general clinical pharmacy interventions are associated with cost savings. Most economic evaluations of clinical pharmacy interventions suffered from a number of methodological limitations relating to the absence of a control group without clinical pharmacy interventions, limited scope of costs and outcomes, focus on direct health care costs only, exclusion of pharmacist employment cost, use of intermediate outcome measures, exclusion of health benefits, and absence of incremental cost analysis. Some avenues for designing future economic evaluations include the use of a control group, detailed descriptions of the interventions provided, evaluations conducted from a societal perspective, consideration of patients' health benefits when assessing economic effect of interventions and hospital costs, and the inclusion of sensitivity and incremental analyses. Conclusion. Most pharmacoeconomic evaluations of clinical pharmacy interventions demonstrated limitations in their methodological quality and applicability to current practice. Future evaluations should use a comparative study design that includes the incremental cost-effectiveness or cost:benefit ratio of clinical pharmacy interventions from a societal perspective.
引用
收藏
页码:1161 / 1172
页数:12
相关论文
共 39 条
[1]   Validation of an instrument for the documentation of clinical pharmacists' interventions [J].
Allenet, Benoit ;
Bedouch, Pierrick ;
Rose, Francois-Xavier ;
Escofier, Laurence ;
Roubille, Renaud ;
Charpiat, Bruno ;
Juste, Michel ;
Conort, Ornella .
PHARMACY WORLD & SCIENCE, 2006, 28 (04) :181-188
[2]  
*AM CANC SOC, 2007, CANC FACTS FIG 2007, P3
[3]  
Bailey TC, 1997, PHARMACOTHERAPY, V17, P277
[4]   Cost savings from having a clinical pharmacist work part-time in a medical intensive care unit [J].
Baldinger, SL ;
Chow, MSS ;
Cannon, RH ;
Kelly, ET .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (24) :2811-2814
[5]   Clinical pharmacy services, pharmacy staffing, and hospital mortality rates [J].
Bond, C. A. ;
Raehl, Cynthia L. .
PHARMACOTHERAPY, 2007, 27 (04) :481-493
[6]   Clinical and economic outcomes of pharmacist-managed antimicrobial prophylaxis in surgical patients [J].
Bond, C. A. ;
Raehl, Cynthia L. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (18) :1935-1942
[7]   Clinical and economic outcomes of pharmacist-managed aminoglycoside or vancomycin therapy [J].
Bond, CA ;
Raehl, CL .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (15) :1596-1605
[8]   Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals [J].
Bond, CA ;
Raehl, CL ;
Franke, T .
PHARMACOTHERAPY, 2002, 22 (02) :134-147
[9]   Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital [J].
Boyko, WL ;
Yurkowski, PJ ;
Ivey, MF ;
Armitstead, JA ;
Roberts, BL .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (14) :1591-1595
[10]   INCIDENCE OF ADVERSE EVENTS AND NEGLIGENCE IN HOSPITALIZED-PATIENTS - RESULTS OF THE HARVARD MEDICAL-PRACTICE STUDY-I [J].
BRENNAN, TA ;
LEAPE, LL ;
LAIRD, NM ;
HEBERT, L ;
LOCALIO, AR ;
LAWTHERS, AG ;
NEWHOUSE, JP ;
WEILER, PC ;
HIATT, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (06) :370-376